General
Preferred name
TAPI1
Synonyms
TAPI-1 ()
(2R)-TAPI-1 ()
TAPI1 acetate ()
P&D ID
PD080151
CAS
163847-77-6
Tags
available
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
25
DESCRIPTION
TAPI1 (TAPI) , an ADAM17/TACE inhibitor, inhibits shedding of cytokine receptors.
PRICE
1843
DESCRIPTION
TAPI1 acetate is a salt form of TAPI1. TAPI1 (TNF-?? processing inhibitor-1) is a TACE (ADAM17) inhibitor that inhibits shedding of TNF-??, TNFRI (p60), and TNFRII (p80), IL-6 other cytokine receptors; TAPI-1 is also a metalloproteinase MMP inhibitor that promotes cisplatin-induced ESCC cell apoptosis by inhibiting the NF-??B signaling pathway to promote cisplatin-induced apoptosis in ESCC cells.
DESCRIPTION
TAPI-1 is a potent inhibitor of matrix metalloproteinases and TACE (TNF-α convertase/ADAM17/α-secretase).
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
3
BOC Sciences Bioactive Compounds
MedChem Express Bioactive Compound Library
Other bioactive compounds
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
12
Molecular Weight
499.28
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
6
Rotatable Bonds
13
Ring Count
2
Aromatic Ring Count
2
cLogP
1.0
TPSA
162.65
Fraction CSP3
0.46
Chiral centers
3.0
Largest ring
6.0
QED
0.18
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
MMP
Pathway
Metabolic Enzyme/Protease
Source data

